Desenvolvimento, Inovação e Saúde: a perspectiva teórica e política do Complexo Econômico-Industrial da Saúde

Abstract

The concept and approach of the Health Economic-Industrial Complex (HEIC) were present in the advancement of the Unified Health System (SUS) in the last decades, contributing to the incorporation of an agenda related to the national pattern of development. The paper reconstructs this approach to capture its dynamics and demarcate the vision developed in this paradigm. It reveals the thinking matrices of the field of political economy that provide the analytical substrate for its development, allowing us to confront the reductionist use of the concept. It highlights, therefore, the logical foundations that guided the public policies resulting from this approach, with emphasis on the systemic approach and the use of state purchasing power, through the Productive Development Partnerships (PDP), marking the effort to articulate the social and economic realms of development. At present, this analytical perspective is even more crucial, showing that well-being not only fits into GDP but can also be a lever for a pattern of development committed to the National Health Universal System (SUS), society and economic and technological sovereignty in health.

Os desafios atuais da luta pelo direito universal à saúde no Brasil

“…To this end, it is necessary to promote policies for industrial development and health science, technology and innovation, which, combined, stimulate national production 27 , at costs that society can afford, of the indispensable supplies to meet the health needs of Brazilians.…”

Medicamentos e pesquisa translacional: etapas, atores e políticas de saúde no contexto brasileiro

“…In the pharmaceutical supply chain, for example, such actions were important to foster public laboratories, institute programs (such as the T h e st ra t e g y o f t h e P ro d u c t i ve Development Partnerships (PDP) is characterized as partnerships between public institutions and private entities, with the objective of transferring innovative and essential technologies to the public, reducing SUS vulnerability and reducing prices charged. In 2014, the strategy had its regulatory framework redefined, establishing process steps and their respective deadlines, in addition to the annual publication of the list of products considered strategic for SUS 35 .…”

“…Leite et al 52 emphasize the need to increase the budget for health funding and the repeal of CA nº 95/2016. Coupled with this, the uncertain future scenario for the funding of research, whether basic or applied, the promotion of public production of medicines and the induction of the Economic-Industrial Health Care Complex, as well as the impact on the capacity of the State to incorporate or not new technologies and the continuous provision of those already incorporated 35,41,53 .…”

Atenção primária e sistemas universais de saúde: compromisso indissociável e direito humano fundamental

“…The organization of a PHC strategy involves local arrangement of the action, community action and territorial interventions, individual and public health actions, the establishment of regional reference and counter-reference networks, the necessary link with specialized and hospital care, the challenges of permanent care of an elderly population with chronic diseases and multi-morbidity, interaction with other services such as social services and those of long-term care, the need for intelligent prediction and vigilance systems that enable anticipating resolutive actions at local, regional and national levels (as revealed by the recent case of the Zika virus), and many other requirements for comprehensive health care, embedded in a universal health care system. Such complexity demands that health needs to be the guiding lines of the national and global research priority agendas so that knowledge becomes an instrument for universal access to health care and comprehensive primary health care 18 .…”